en
Scientific article
English

Community-acquired pneumonia: causes of treatment failure in patients enrolled in clinical trials

Published inClinical microbiology and infection, vol. 9, no. 9, p. 949-954
Publication date2003
Abstract

In order to determine the causes of treatment failure in community-acquired pneumonia (CAP) clinical trials, a MEDLINE search for all CAP studies published between 1990 and 1997 was performed. Prospective, randomized studies comparing the efficacy of two or more antibiotics in CAP were selected. Treatment failure was defined as persistent fever, deterioration of patient's condition, or a change in the prescribed antibiotic regimen. In 16% of the cases included in the clinical trials, the treatment of CAP is unsuccessful. A significant number of identified failure cases were owing to antibiotic side-effects. Resistant pathogens are an unusual cause of failure whatever the antibiotic used.

Keywords
  • Aged
  • Anti-Bacterial Agents/ therapeutic use
  • Community-Acquired Infections/ drug therapy
  • Humans
  • Pneumonia/ drug therapy
  • Randomized Controlled Trials as Topic/ methods
  • Retrospective Studies
  • Treatment Failure
Citation (ISO format)
GENNE, Daniel et al. Community-acquired pneumonia: causes of treatment failure in patients enrolled in clinical trials. In: Clinical microbiology and infection, 2003, vol. 9, n° 9, p. 949–954.
Main files (1)
Article
accessLevelRestricted
Identifiers
ISSN of the journal1198-743X
528views
0downloads

Technical informations

Creation06/21/2010 10:24:25 AM
First validation06/21/2010 10:24:25 AM
Update time03/14/2023 3:43:49 PM
Status update03/14/2023 3:43:49 PM
Last indexation02/12/2024 6:30:42 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack